Abstract
Purpose. The purpose of this study was to investigate the potential of poly(lactide-co-glycolide) (PLGA) microspheres to stabilize and deliver the analogue of camptothecin, 10-hydroxycamptothecin (10-HCPT).
Methods. 10-HCPT was encapsulated in PLGA 50:50 microspheres by using an oil-in-water emulsion-solvent evaporation method. The influence of encapsulation conditions (i.e., polymer molecular weight (Mw), polymer concentration, and carrier solvent composition) on the release of 10-HCPT from microspheres at 37°C under perfect sink conditions was examined. Analysis of the drug stability in the microspheres was performed by two methods:i) by extraction of 10-HCPT from microspheres and ii). by sampling release media before lactone— carboxylate conversion could take place.
Results. Microspheres made, of low Mw polymer (inherent viscosity 0.15 dl/g) exhibited more continuous drug release than those prepared from polymers of higher Mw (i.v. = 0.58 and 1.07 dl/g). In addition, a high polymer concentration and the presence of cosolvent in the carrier solution to dissolve 10-HCPT were both necessary in the microsphere preparation in order to eliminate a large initial burst of the released 10-HCPT. An optimal microsphere formulation released 10-HCPT slowly and continuously for over two months with a relatively small initial burst of the released drug. Both analytical methods used to assess the stability of 10-HCPT revealed that the unreleased camptothecin analogue in the microspheres remained in its active lactone form (>95%) over the entire 2-month duration of study.
Conclusions. PLGA carriers such as those described here may be clinically useful to stabilize and deliver camptothecins for the treatment of cancer.
Similar content being viewed by others
REFERENCES
M. Potmesil and H. Pinedo. Camptothecins: New Anticancer Agents, CRC Press, Ann Arbor, 1995.
J. Dancey and E. A. Eisenhauer. Br. J. Cancer. 74:183-205 (1996).
W. Dahut, N. Harold, K. Takimoto, C. Allegra, A. Chen, M. J. Hamilton, S. Arbuck, M. Sorensen, F. Grollman, H. Nakashima, R. Lieberman, M. Liang, W. Corse, and J. Grem. J. Clin. Oncol. 14:1236-1244 (1996).
J. Hochster, L. Liebes, J. Speyer, J. Sorich, B. Taubes, R. Oratz, J. Wernz, A. Chachoua, B. Raphael, R. Z. Vinci, and R. H. Bloom. J. Clin. Oncol. 12:553-559 (1994).
R. H. Hertzberg, M. J. Caranfa, K. G. Holden, D. J. Jakas, G. Gallagher, M. R. Mattern, S. Mong, J. O. Bartus, R. K. Johnson, and W. D. Kingsbury. J. Med. Chem. 32:715-720 (1994).
W. D. Wani, P. E. Ronman, J. T. Lindley, and M. E. Wall. J. Med. Chem. 23:554-560 (1980).
J. Fassberg and V. J. Stella. J. Pharm. Sci. 81:676-684 (1992).
T. G. Burke and Z. Mi. J. Med. Chem. 36:2580-2582 (1993).
T. G. Burke and X. Gao. J. Pharm. Sci. 83:967-969 (1994).
R. B. Greenwald, A. Pendri, C. Conover, C. Gilbert, R. Yang, and J. Xia. J. Med. Chem. 39:1938-1940 (1996).
D. H. Lewis. In M. Chasin and R. Langer (eds). Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, 1990, pp. 1-41.
H. Okada and H. Toguchi. Crit. Rev. in Therapeutic Drug Carrier Systems. 12:1-99 (1995).
R. Langer. Science. 249:1527-1533 (1990).
S. P. Schwendeman, M. Cardamone, A. Klibanov and R. Langer. In S. Cohen and H. Bernstein (eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 1-49.
C. Thies. In M. Donbrow (ed.), Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Ann Arbor, 1991, pp. 47-71.
T. G. Burke, A. K. Mishra, M. C. Wani and M. E. Wall. Biochemistry. 32:5352-5364 (1993).
L. Slade and H. Levine. Crit. Rev. Food Sci. Nutr. 30:115-360 (1991).
F. G. Hutchinson and B. J. A. Furr. J. Controlled Release. 13:279-294 (1990).
T. G. Park. J. Controlled Release. 30:161-173 (1994).
S. M. Li, H. Garreau, and M. Vert. J. Mater. Sci: Mater. Med. 1:123-130 (1990).
P. M. J. Flandroy, C. Grandfils, P. J. Jerome. In A. Rolland (ed), Pharmaceutical Particulate Carriers: Therapeutic Applications, Marcel Dekker, New York, 1993, pp. 321-366.
G. Spenlehauer, M. Veillard, and J.-P. Benoit. J. Pharm. Sci. 75:750-755 (1986).
K. Juni, J. Ogata, M. Nakano, T. Ichihara, K. Mori, and M. Akagi. Chem. Pharm. Bull. 33:313-318 (1985).
P. K. Gupta, C. T. Hung, and F. C. Lam. In A. Rolland (ed.), Pharmaceutical Particulate Carriers: Therapeutic Applications, Marcel Dekker, New York, 1993; pp. 135-165.
H. Brem, S. Piatadosi, P. C. Burger, M. Walker, R. Selker, N. A. Vick, K. Black, M. Sisti, S. Brem, G. Mohr, P. Muller, R. Morawetz, and S. C. Schold. Lancet. 345:1008-1012 (1995).
L. K. Fung, M. Shin, B. Tyler, H. Brem, and W. M. Saltzman. Pharm. Res. 13:671-682 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shenderova, A., Burke, T.G. & Schwendeman, S.P. Stabilization of 10-Hydroxycamptothecin in Poly(lactide-co-glycolide) Microsphere Delivery Vehicles. Pharm Res 14, 1406–1414 (1997). https://doi.org/10.1023/A:1012172722246
Issue Date:
DOI: https://doi.org/10.1023/A:1012172722246